Prothrombin Mutation Analysis – Accurate DNA Analysis for Thrombophilia Detection

Unlock critical insights into your genetic predisposition to blood clotting disorders with the Prothrombin Mutation Analysis—a precise, laboratory-based DNA test designed to detect the presence of the G20210A mutation in the prothrombin (F2) gene. This single nucleotide change is a well-established genetic risk factor for thrombophilia, a condition that increases the likelihood of abnormal blood clot formation, potentially leading to deep vein thrombosis (DVT), pulmonary embolism (PE), and other serious complications.

Key Features:

• High-Sensitivity DNA Testing: Utilizes advanced PCR (Polymerase Chain Reaction) and allele-specific detection methods to accurately identify the G20210A mutation in the prothrombin gene.

• Comprehensive Genotyping: Determines whether the individual is heterozygous (one copy of the mutation) or homozygous (two copies), providing essential information for risk stratification.

• Fast Turnaround Time: Results typically available within 5–7 business days, enabling timely clinical decision-making.

• CLIA-Certified Laboratory: Testing performed in a certified and accredited laboratory to ensure the highest standards of accuracy and reliability.

• Physician-Reviewed Report: Each result is reviewed and interpreted by a qualified medical professional, with clear explanations and actionable insights.

Benefits:

• Personalized Risk Assessment: Understand your inherited risk for developing blood clots, especially if you have a personal or family history of thrombosis, recurrent pregnancy loss, or unexplained stroke.

• Informed Medical Decisions: Supports healthcare providers in tailoring anticoagulation therapy, surgical planning, and contraceptive or hormone replacement therapy choices.

• Family Planning Support: Offers valuable information for individuals considering pregnancy or fertility treatments, as the mutation can impact maternal and fetal health.

• Preventive Health Advantage: Enables proactive lifestyle and medical interventions to reduce the risk of clot-related complications.

Who Should Consider This Test:

• Individuals with a personal or family history of venous thromboembolism (VTE)

• Women with recurrent miscarriages or complications during pregnancy

• Patients undergoing surgery or long-term immobilization

• Individuals considering estrogen-based medications or hormone therapy

• First-degree relatives of individuals known to carry the prothrombin mutation

Value Proposition:

The Prothrombin Mutation Analysis empowers individuals and healthcare providers with critical genetic information that can shape preventive strategies, guide treatment decisions, and ultimately improve health outcomes. By identifying a key genetic risk factor for thrombophilia, this test offers peace of mind and a proactive path toward better vascular health. Whether used as part of a broader thrombophilia panel or as a standalone diagnostic tool, it delivers clarity, confidence, and control over your health journey.